Fluorescence in‐situ hybridisation for TP63 rearrangements in T cell lymphomas: single‐site experience of 470 patients and implications for clinical testing
暂无分享,去创建一个
A. Feldman | R. Ketterling | P. Greipp | L. Baughn | R. Knudson | R. Meyer | Kathryn E. Pearce | Jess F. Peterson | Reid G. Meyer
[1] Joshua M. Dempster,et al. Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models , 2018, Nature Communications.
[2] Z. Xiao,et al. A double dealing tale of p63: an oncogene or a tumor suppressor , 2017, Cellular and Molecular Life Sciences.
[3] M. Lim,et al. Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] O. Abdel-Wahab,et al. Diagnosis and classification of hematologic malignancies on the basis of genetics. , 2017, Blood.
[5] A. Feldman,et al. DUSP22 AND TP63 REARRANGEMENTS PREDICT OUTCOME OF ALK‐NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA: A DANISH COHORT STUDY , 2017, Blood.
[6] A. Feldman,et al. Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping. , 2017, Human pathology.
[7] G. Inghirami,et al. The heterogeneous landscape of ALK negative ALCL , 2017, Oncotarget.
[8] Sarah H. Johnson,et al. Chromosomal rearrangements and copy number abnormalities of TP63 correlate with p63 protein expression in lung adenocarcinoma , 2015, Modern Pathology.
[9] A. Feldman,et al. Anaplastic Large Cell Lymphomas: ALK Positive, ALK Negative, and Primary Cutaneous , 2015, Advances in anatomic pathology.
[10] A. Feldman,et al. Somatic rearrangement of the TP63 gene preceding development of mycosis fungoides with aggressive clinical course , 2014, Blood Cancer Journal.
[11] W. Wilson,et al. ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. , 2014, Blood.
[12] David I. Smith,et al. Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. , 2012, Blood.
[13] Ryan D. Morin,et al. TBL1XR1/TP63: a novel recurrent gene fusion in B-cell non-Hodgkin lymphoma. , 2012, Blood.
[14] David I. Smith,et al. Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing. , 2011, Blood.